CCAAT/enhancer binding protein beta as a potential oncoprotein in non-small cell lung cancer

被引：0
|
作者：
Thoennissen, N. H. [1 ]
Thoennissen, G. B. [1 ]
Evers, G. [2 ]
Sauer, T. [2 ]
Schmidt, L. H. [2 ]
Ikezoe, T. [3 ]
Gombart, A. F. [4 ]
Koeffler, H. P. [4 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hamburg, Germany
[2] Univ Munster, Dept Med A, D-48149 Munster, Germany
[3] Kochi Univ, Dept Hematol & Resp Med, Kochi 780, Japan
[4] Cedars Sinai Med Ctr, Hem Onc Dept, Los Angeles, CA 90048 USA
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P218
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] An oncogenic role for CCAAT/enhancer binding protein beta in non-small cell lung cancer
    Thoennissen, Nils H.
    Lwanski, Gabriela B.
    Ji, Jianfei
    Lkezoe, Takayuki
    Lee, Kunik
    Adachi, Yoshihiro
    Takeuchi, Tamotsu
    Furihata, Mutsuo
    Park, Dorothy J.
    Gombart, Adrian F.
    Koeffler, H. Phillip
    CANCER RESEARCH, 2010, 70
  • [2] Misexpression of CCAAT/enhancer binding protein beta causes osteopenia
    Zanotti, Stefano
    Stadmeyer, Lisa
    Smerdel-Ramoya, Anna
    Durant, Deena
    Canalis, Ernesto
    JOURNAL OF ENDOCRINOLOGY, 2009, 201 (02) : 263 - 274
  • [3] Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer
    Liu, Jun
    Jia, Jingyi
    Wang, Siqiao
    Zhang, Junfang
    Xian, Shuyuan
    Zheng, Zixuan
    Deng, Lin
    Feng, Yonghong
    Zhang, Yuan
    Zhang, Jie
    MOLECULES, 2022, 27 (13):
  • [4] E6 Oncoprotein Expression in Non-Small Cell Lung Cancer Patients
    Cho, Jung Nam
    Yoon, So Yeon
    Hyun, Dae Sung
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2011, 71 (05) : 349 - 354
  • [5] CCAAT/Enhancer Binding Protein β Is Dispensable for Development of Lung Adenocarcinoma
    Cai, Yi
    Hirata, Ayako
    Nakayama, Sohei
    VanderLaan, Paul A.
    Levantini, Elena
    Yamamoto, Mihoko
    Hirai, Hideyo
    Wong, Kwok-Kin
    Costa, Daniel B.
    Watanabe, Hideo
    Kobayashi, Susumu S.
    PLOS ONE, 2015, 10 (03):
  • [6] Epigenetic modulation of tumor suppressor CCAAT/Enhancer binding protein a activity in lung cancer
    Tada, T
    Brena, RMT
    Hackanson, B
    Morrison, C
    Otterson, GA
    Plass, C
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (06): : 396 - 406
  • [7] Retinoblastoma associated binding protein 46: a potential prognostic marker for distal metastasis in non-small cell lung cancer
    Wang, Chih-Liang
    Wang, Chun-I
    Liao, Pao-Chi
    Liang, Ying
    Wu, Chih-Ching
    Chuang, Wen-Yu
    Tsai, Ying-Huang
    Chen, Hua-Chien
    Yu, Jau-Song
    Yu, Chia-Jung
    FASEB JOURNAL, 2009, 23
  • [8] Ipilimumab: its potential in non-small cell lung cancer
    Tomasini, Pascale
    Khobta, Nataliya
    Greillier, Laurent
    Barlesi, Fabrice
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (02) : 43 - 50
  • [9] A potential agent for treating non-small cell lung cancer
    Ou, Jing-Song
    Huang, Da-De
    Ou, Zhi-Jun
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (09): : 985 - 986
  • [10] The potential of antiangiogenic therapy in non-small cell lung cancer
    Giaccone, Giuseppe
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 1961 - 1970
12345